Skip to Main Content

Paper Details

Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020.
JAMA Neurol
11
2023
COVID, COVID-19, Central nervous system infection/demyelination, Children, Guillain-Barr syndrome, MIS-C, Multisystem Inflammatory Syndrome, Neurologic Involvement, Patients, SARS, SARS-CoV, SARS-CoV-2, SARS-CoV-2-, acute fulminant cerebral edema, central nervous system infection, children, coronavirus 2, demyelination, encephalitis, encephalopathy, meningitis, multisystem inflammatory syndrome, neurologic, neurologic deficits, neurologic disorders, neurologic involvement, nonhemorrhagic leukoencephalopathy, patients, reverse transcriptase, severe acute respiratory syndrome coronavirus 2, stroke, transverse myelitis
Author NameAffiliation
Kerri L LaRovereBoston Children's Hospital
Tina Young PoussaintBoston Children's Hospital
Tracie C WalkerUniversity of North Carolina at Chapel Hill Children's Hospital
Melania M BembeaJohns Hopkins School of Medicine
Kari WellnitzUniversity of Iowa Carver College of Medicine
Natalie Z CvijanovichUCSF Benioff Children's Hospital
Mark W HallNationwide Children's Hospital
Julie C FitzgeraldUniversity of Pennsylvania Perelman School of Medicine
Natasha B HalasaVanderbilt University Medical Center
Shira J GertzCooperman Barnabas Medical Center
Adam J Schwarz
Katri V TyppoDepartment of Pediatrics and Banner Children's at Diamond Children's Medical Center, University of Arizona
Laura L LoftisTexas Children's Hospital
John S GiulianoYale University School of Medicine
Courtney M RowanIndiana University School of Medicine, Riley Hospital for Children
Aline B MadduxUniversity of Colorado School of Medicine and Children's Hospital Colorado
Sabrina M HeidemannCentral Michigan University
Adrienne G RandolphBoston Children's Hospital
Adrienne G RandolphHarvard Medical School
  • 1 - 19

Datasets

Release 1.2